Edronax


Also found in: Dictionary, Thesaurus, Wikipedia.

Edronax®

Reboxetine mesylate Pharmacology A selective noradrenaline reuptake inhibitor–NARI for treating depression

Edronax

A brand name for REBOXETINE.
Mentioned in ?
References in periodicals archive ?
In clinical studies that compared Edronax with two tricyclic antidepressants, imipramine and desipramine, Edronax was shown to have a lower frequency of side effects.
P&U) announced today that it has received marketing authorization from the United Kingdom Medicines Control Agency to market Edronax Tablets (reboxetine) for the treatment of depressive illness.
Hassan reported that Xalatan, a novel therapy for glaucoma, is making a good contribution to the top line and that the company expects immediate top-line contributions from Edronax and Detrusitol.
The selective activity of Edronax on noradrenaline appears to help restore patients' energy and motivation for improved social functioning.
In controlled clinical studies with more than 2,000 patients, Edronax was shown to be effective in the acute treatment of depressive illness/major depression.
Edronax is also approved in Sweden, Denmark, Ireland, Austria and Finland.
Edronax belongs to a new class of antidepressants known as selective noradrenaline reuptake inhibitors.
Indicated for the acute treatment of depressive illness/major depression, Edronax was first approved in the United Kingdom in April 1997.